OncLive® On Air

Hodgkin's Lymphoma

Chemotherapy

Oncology

Colorectal Cancer

Nivolumab

Onc201

Hepatic Artery Infusion

H3K27M Mutant Diffuse Midline Gliomas

Immunotherapy

ACTION Trial

CAR T-Cell Therapy

Her2-Positive Breast Cancer

Ponatinib

FDA Approval

Swog 1826

Siltocaptagine Autolucel

Multiple Myeloma

Colorectal Cancer Management

Malignant Perivascular Epithelioid Cell Tumors

Glioma

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers,... more

31 ratings

Publishes	Daily	Episodes	500	Founded	8 years ago
Number of Listeners		Categories	ScienceHealth & Fitness

Listen to this Podcast

Guests Hosts Reviews Charts Talking Points

Latest Episodes

S15 Ep48: Multidisciplinary Teams Optimize Surgical and Therapeutic Roles in Advanced CSCC Care: With Eric Whitman, MD; and Vishal Patel, MD, FAAD, FACMS

In today’s episode, our discussion features Eric Whitman, MD; and Vishal Patel, MD, FAAD, FACMS. Dr Whitman is medical director of the oncology service line with Atlantic Health System in Morristown, New Jersey. Dr Patel is an associate professor of ... more

31 Jan 2026 • 24 min

S15 Ep47: ASCENT-07 Trial Propels Further Questions About the Role of Earlier-Line ADCs in HR+ Metastatic Breast Cancer: With Komal Jhaveri, MD, FACP

In today’s episode, the discussion features Komal Jhaveri, MD, FACP, a breast medical oncologist at Memorial Sloan Kettering Cancer Center, who reviewed the evolving role of TROP2-directed antibody–drug conjugates (ADCs) in the management of hormone ... more

31 Jan 2026 • 12 min

S15 Ep46: Expanded BTK Inhibitor Research Directs the Evolution of Pirtobrutinib Use in CLL: With Andrew Lipsky, MD

In today’s episode, Andrew Lipsky, MD, reviewed recent updates with BTK inhibitors in the chronic lymphocytic leukemia (CLL) treatment paradigm, including the clinical significance of the December 2025 FDA approval of pirtobrutinib (Jaypirca) in rela... more

31 Jan 2026 • 20 min

S15 Ep45: Early, Reflex Biomarker Testing Is Critical to Optimizing NSCLC Treatment Decisions Across Disease Stages: With Adam Fox, MD, and Cynthia A. Schandl, MD, PhD

In today’s episode, the discussion features Adam Fox, MD, an assistant professor in the Department of Medicine at the College of Medicine at the Medical University of South Carolina in Charleston, and Cynthia A. Schandl, MD, PhD, medical director of ... more

30 Jan 2026 • 14 min

Key Facts

Accepts Guests

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Oncology Brothers: Practice-Changing Cancer DiscussionsOncology Brothers

Oncology Today with Dr Neil LoveDr. Neil Love

Research To Practice | Oncology VideosDr Neil Love

ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)

OncoPharmJohn Bossaer

Recent Guests

Rahul Banerjee

MD, FACP specialized in oncology

Episode: S15 Ep28: Emerging CELMoDs Set New Standards for Efficacy and Tolerability in Myeloma: With Rahul Banerjee, MD, FACP

Lorenzo Falchi, MD

Clinical and regulatory expert discussing FDA approval

Episode: S15 Ep26: FDA Approval Insights: Epcoritamab Plus Rituximab/Lenalidomide for Relapsed/Refractory Follicular Lymphoma: With Lorenzo Falchi, MD

Surbhi Sidana, MD

Associate professor of medicine and leader of Myeloma CAR-T Immunotherapy Program at Stanford University.

Stanford University

Episode: S15 Ep25: FDA Approval Insights: BVd for Relapsed/Refractory Multiple Myeloma: With Surbhi Sidana, MD

Jonathan R. Strosberg

Professor and leader in the Neuroendocrine Tumor Division and the Department of Gastrointestinal Oncology Research Program at Moffitt Cancer Center

Moffitt Cancer Center

Episode: S15 Ep24: PRRT With 177Lu-Edotreotide Improves Outcomes vs Everolimus in Metastatic GEP-NETs: With Jonathan R. Strosberg, MD

Valentina Bonev

Breast Surgical Oncologist

Breast Lake

Episode: S15 Ep23: Experts Explore Intersections Between Breast Surgery and Radiation for Comprehensive Care: With Hirsch Matani, MD; Elizabeth Zhang-Velten, MD; and Valentina Bonev, MD, DABS, FACS, FSSO

Jason Mouabbi, MD

Oncologist discussing ctDNA testing in breast cancer management

OncLive

Episode: S15 Ep18: ctDNA Testing Opens Avenues for the Future of Breast Oncology: With Jason Mouabbi, MD

Pooja M. Phull, MD

A hematologist oncologist with the John Theurer Cancer Center at Hackensack University Medical Center

John Theurer Cancer Center, Hackensack University Medical Center

Episode: S15 Ep17: Microbiome Profiling Highlights Impact of Butyrate Loss on Post-Transplant Outcomes in Multiple Myeloma: With Pooja M. Phull, MD

Panagiotis Konstantinopoulos

Attending Medical Oncologist at Dana-Farber, Professor of Medicine at Harvard Medical School, Director of Translational Research

Dana-Farber Cancer Institute

Episode: S15 Ep14: Optimized Immunotherapy Use and Novel Therapeutic Targets Move the Needle for Endometrial Cancer Management: With Ursula A. Matulonis, MD; and Panagiotis (Panos) A. Konstantinopoulos, MD, PhD

Sarah Rutherford, MD

Expert on lymphoma treatment and minimal residual disease

Not Specified

Episode: S15 Ep10: ctDNA Assays Are Poised to Reshape Lymphoma Treatment Strategies: With Sarah Rutherford, MD

Hosts

Gregory J. Tiesi

Chief of Surgical Oncology discussing innovative regional cancer therapies and patient management strategies.

Unknown

Host of interviews with various oncologists and discussions around oncology practices and updates.

Reviews

4.5 out of 5 stars from 31 ratings

Best option for CME podcasts
Love the content! Easily the best platform for listening to CME and staying updated while on the go. Keep up the great work!
Apple Podcasts
5
Dlshaka
United States7 months ago
My favorite podcast for oncology
This podcast provides excellent information to anyone who works in the medical field on oncology.
Apple Podcasts
5
Chiliman1986
United States6 years ago

Embed These Reviews on a Website

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

The discussions are informative for professionals in the medical field, making it a valuable resource for anyone working in oncology.

Listeners appreciate the high-quality content focused on the latest advancements in oncology.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts

#173

Hong Kong/Health & Fitness

Talking Points

Recent interactions between the hosts and their guests.

S15 Ep34: Cases and Conversations™: Transforming Small Cell Lung Cancer Treatment Through Emerging Evidence and Expert Insights

Q: What is the importance of early-stage surgical considerations in small cell lung cancer treatments?

Surgery can be pivotal for very early-stage disease to ensure appropriate pathology and treatment post-surgery, highlighting the need for multidisciplinary approaches in decision-making.

S15 Ep34: Cases and Conversations™: Transforming Small Cell Lung Cancer Treatment Through Emerging Evidence and Expert Insights

Q: What are the current patterns of practice for treating patients with limited stage small cell lung cancer?

It depends on the patient's operability and tumor staging; treatment options include lobectomy for early-stage cases, SBRT for medically inoperable patients, and concurrent chemo-radiation followed by immunotherapy for others.

S15 Ep32: Lisaftoclax Plus Azacitidine May Make New Inroads in Higher-Risk MDS Management: With Guillermo Garcia-Manero, MD

Q: Is there any other exciting ongoing research in MDS that you'd like to highlight?

Ongoing research in MDS focuses on better patient outcomes through thoughtful protocol design and considering BCL2 inhibitors for patients who may benefit from them.

S15 Ep32: Lisaftoclax Plus Azacitidine May Make New Inroads in Higher-Risk MDS Management: With Guillermo Garcia-Manero, MD

Q: What was the mechanism reaction of Lecyptoclax?

Lecyptoclax is described as a second-generation BCL2 inhibitor with a different pharmacological profile compared to Venetoclax, resulting in fewer drug interactions and a potentially safer profile.

S15 Ep12: VISION Data Show Promise of Tepotinib in Treatment-Naive NSCLC Harboring MET Exon 14 Skipping Mutations: With Catherine Shu, MD

Q: But is there anything else that you wanted to add here about some safety considerations?

In general, tepotinib was tolerated quite well; however, patients commonly experience peripheral edema, which can be bothersome and often requires management strategies.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About OncLive® On Air

What is OncLive® On Air about and what kind of topics does it cover?

Content focuses on discussions with leading oncologists covering a broad spectrum of topics in oncology, including systemic therapies, surgical techniques, and innovations in radiation therapy. Episodes reflect on the latest advancements and therapeutic approaches across various cancer types, such as lung, breast, gastrointestinal, and hematologic malignancies, as well as gynecologic and genitourinary cancers. The informative interviews not only present the current state of cancer treatment but also emphasize the importance of research and clinical trials in shaping future strategies for cancer care.

Where can I find podcast stats for OncLive® On Air?

Rephonic provides a wide range of podcast stats for OncLive® On Air. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to OncLive® On Air and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does OncLive® On Air get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for OncLive® On Air, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for OncLive® On Air?

Rephonic provides comprehensive predictive audience data for OncLive® On Air, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does OncLive® On Air have?

To see how many followers or subscribers OncLive® On Air has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to OncLive® On Air?

These podcasts share a similar audience with OncLive® On Air:

1. Oncology Brothers: Practice-Changing Cancer Discussions
2. Oncology Today with Dr Neil Love
3. Research To Practice | Oncology Videos
4. ASCO Daily News
5. OncoPharm

How many episodes of OncLive® On Air are there?

OncLive® On Air launched 8 years ago and published 500 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact OncLive® On Air?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for OncLive® On Air?

Rephonic pulls ratings and reviews for OncLive® On Air from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for OncLive® On Air?

Rephonic provides full transcripts for episodes of OncLive® On Air. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on OncLive® On Air?

Recent guests on OncLive® On Air include:

1. Rahul Banerjee
2. Lorenzo Falchi, MD
3. Surbhi Sidana, MD
4. Jonathan R. Strosberg
5. Valentina Bonev
6. Jason Mouabbi, MD
7. Pooja M. Phull, MD
8. Panagiotis Konstantinopoulos

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days